Evidence map›Paper›PMID 42800601›Full record

ArticleExperimental neurology2026

Gene expression and brain pathology at the early stages of bilateral chronic cerebral hypoperfusion in the female mouse brain.

Sarra Limam, Alfonse Mazzarella, Randall Hernandez-Jimenez, Ankit Patel, Ashley Hedrick, Rebecca Nieves, Mitali Chaudhari, Jude Bayyat, Danielle Gulick, Ashutosh Dharap

Abstract read
In one paragraph

Article in Experimental neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarra LimamDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America.
Alfonse MazzarellaDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America.
Randall Hernandez-JimenezDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America.
Ankit PatelDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America.
Ashley HedrickDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America.
Rebecca NievesDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America.
Mitali ChaudhariDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America.
Jude BayyatDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America.
Danielle GulickDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America.
Ashutosh DharapDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, United States of America; USF Health Byrd Alzheimer's Center & Research Institute, University of South Florida, Tampa, FL 33613, United States of America. Electronic address: dharap@usf.edu.

Funding

Enhancer RNAs and enhancer-centric gene regulatory networks in vascular dementiaR03AG084918 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI DHARAP, ASHUTOSH · 2024 to 2025
$300k
NIA NIH HHS R03 AG084918
6 · The paper itself

Abstract

Chronic cerebral hypoperfusion (CCH) is a major risk factor for neurodegenerative diseases, including vascular dementia (VD). It is well documented that sex differences account for variability in progression and outcomes in cerebrovascular pathophysiology and dementia risk. Despite extensive study of VD, most mechanistic and preclinical work has been conducted in male animals, leaving the molecular and cellular consequences of CCH in the female brain largely unexplored. To address this critical gap in knowledge, we investigated the effects of short-term CCH on pathology and gene expression changes in 6-7-month-old female C57BL/6 J mice using the bilateral common carotid artery stenosis (BCAS) mouse model. Thirty days following BCAS surgery, the mice exhibited early pathological changes such as pyknotic nuclei and moderate white matter damage, cellular changes such as astrocytic activation and clusters of degenerating neurons in the cortex and hippocampus, and gene expression alterations primarily related to extracellular matrix remodeling and mRNA splicing, with no significant changes in hippocampal-dependent spatial working memory. Together, our study demonstrates that pathological changes in the female brain begin to emerge as early as 30-35 days of continuous CCH.

Indexed as

BCASChronic cerebral hypoperfusionCognitive dysfunctionFemaleGene expression

Identifiers

PMID42800601
PMCPMC13671198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.